PTPN6 mutations have been reported in several cancers; the total incidence of such mutations is 2.7% (uterine carcinosarcoma, 7.01%; testicular germ cell carcinoma, 6.04%; ovarian cancer, 5.82%; and melanoma, 5.18%). Here, PTPN6 is linked to ovarian cancer.